Jim Kenney (formerly of Harvard Pilgrim) leads a discussion on advancements in psoriasis treatment, emphasizing the need for early diagnosis and tailored care, especially for skin of color patients who may face diagnostic delays. Joined by Dr. Heather Woolery-Lloyd (Johns Hopkins School of Medicine) and Jason Harris (National Psoriasis Foundation), the conversation covers the broad spectrum of psoriasis treatments, from topical therapies to biologics, and highlights the importance of considering patient preferences and comorbidities in treatment planning. They also discuss the challenges of access to care, the impact of psoriasis on mental health, and the evolving landscape of treatment options, emphasizing a multidisciplinary approach to manage this complex condition effectively.

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/psoriasis-advancements/.